Bayovac® SRS, a proprietary and novel multi-subunit recombinant vaccine for farmed salmon, has demonstrated superior protection against salmon rickettsial septicemia (SRS). SRS is the major infectious disease in Chilean aquaculture, typically killing upwards of 20% of untreated farmed salmon, which represent the highest value per pound of all farmed animals.
Bayovac® SRS was launched following regulatory approval in September 2004. Diversa manufactures this product and Bayer Animal Health distributes this product in Chile, which produces 40% of the world’s farmed salmon.
